Cell cycle regulation and proliferation in lichen sclerosus

Regulatory Peptides

Volumn 167, Issue 2-3, 2011, Pages 209-214

  Gambichler, Thilo ^a   Kammann, Sara ^a   Tigges, Christian ^a   Kobus, Stephan ^a   Skrygan, Marina ^a   Meier, Juris J ^a   Köhler, Christina U ^a   Scola, Nina ^a   Stücker, Markus ^a   Bechara, Falk G ^a   Altmeyer, Peter ^a   Kreuter, Alexander ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cell cycle regulators; Ki 67; Lichen sclerosus; Minichromosome maintenance proteins; P53; Proliferation; Tumour suppressor genes

Indexed keywords

CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 3; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROTEIN P16; PROTEIN P21; PROTEIN P53;

ADULT; ARTICLE; CANCER RISK; CELL CYCLE REGULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MALIGNANT TRANSFORMATION; OXIDATIVE STRESS; PENIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PUNCH BIOPSY; SKIN DEFECT; VULVA;

AGED; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; NUCLEAR PROTEINS;

EID: 79953220075     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.02.003     Document Type: Article

References (35)

1. Powell J.J., Wojnarowska F. Lichen sclerosus. Lancet 1999, 353:1777-1783.
2. Powell J.J., Wojnarowska F., Winsey S., Marren P., Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000, 142:481-484.
3. Regauer S. Immune dysregulation in lichen sclerosus. Eur J Cell Biol 2005, 84:273-277.
4. Gambichler T., Skrygan M., Tigges C., Kobus S., Gläser R., Kreuter A. Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus. Br J Dermatol 2009, 161:1136-1142.
5. Smith Y.R., Haefner H.K. Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol 2004, 5:105-125.
6. Preti M., Rouzier R., Mariani L., et al. Superficially invasive carcinoma of the vulva: diagnosis and treatment. Clin Obstet Gynecol 2005, 48:862-868.
7. Prowse D.M., Ktori E.N., Chandrasekaran D., Prapa A., Baithun S. Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma. Br J Dermatol 2008, 158:261-265.
8. Tachibana K.E., Gonzalez M.A., Coleman N. Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 2005, 205:123-129.
9. Regauer S., Liegl B., Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology 2005, 47:340-347.
10. Gambichler T., Bischoff S., Bechara F.G., Altmeyer P., Kreuter A. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders. J Dermatol Sci 2008, 49:125-132.
11. Papadopoulos O., Betsi E., Tsakistou G., Frangoulis M., Kouvatseas G., Anagnostakis D., Kouvidou Ch. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the penis. Anticancer Res 2007, 27:2167-2174.
12. Rolfe K.J., Crow J.C., Benjamin E., Reid W.M., Maclean A.B., Perrett C.W. Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions. Int J Gynecol Cancer 2001, 11:381-386.
13. van der Avoort I.A., van der Laak J.A., Paffen A., Grefte J.M., Massuger L.F., de Wilde P.C., de Hullu J.A., Bulten J. MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva. Mod Pathol 2007, 20:770-778.
14. Rolfe K.J., MacLean A.B., Crow J.C., Benjamin E., Reid W.M., Perrett C.W. TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer 2003, 89:2249-2253.
15. Vanin K., Scurry J., Thorne H., Yuen K., Ramsay R.G. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. J Invest Dermatol 2002, 119:1027-1033.
16. Carlson J.A., Lamb P., Malfetano J., Ambros R.A., Mihm M.C. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 1998, 11:844-854.
17. Tan S.H., Derrick E., McKee P.H., Hobbs C., Ridley M., Neill S. Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. J Cutan Pathol 1994, 21:316-323.
18. Rolfe K.J., Eva L.J., MacLean A.B., Crow J.C., Perrett C.W., Reid W.M. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer 2001, 11:113-118.
19. Carlson J.A., Amin S., Malfetano J., Tien A.T., Selkin B., Hou J., Goncharuk V., Wilson V.L., Rohwedder A., Ambros R., Ross J.S. Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus. Appl Immunohistochem Mol Morphol 2001, 9:150-163.
20. Hantschmann P., Sterzer S., Jeschke U., Friese K. P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus. Anticancer Res 2005, 25:1739-1745.
21. Liegl B., Regauer S. p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN). Histopathology 2006, 48:268-274.
22. Raspollini M.R., Asirelli G., Moncini D., Taddei G.L. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. Am J Obstet Gynecol 2007, 197:592.e1-592.e5.
23. Nissi R., Kotila V., Knuuti E., Väre P.O., Kauppila S. Altered p53 and Bcl-2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment. Br J Dermatol 2009, 161:958-960.
24. Santos M., Montagut C., Mellado B., García A., Ramón y Cajal S., Cardesa A., Puig-Tintoré L.M., Ordi J. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol 2004, 23. 206-14.
25. Davidson E.J., Morris L.S., Scott I.S., Rushbrook S.M., Bird K., Laskey R.A., Wilson G.E., Kitchener H.C., Coleman N., Stern P.L. Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia. Br J Cancer 2003, 88:257-262.
26. Hoevenaars B.M., van der Avoort I.A., de Wilde P.C., Massuger L.F., Melchers W.J., de Hullu J.A., Bulten J. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int J Cancer 2008, 123:2767-2773.
27. Soufir N., Queille S., Liboutet M., Thibaudeau O., Bachelier F., Delestaing G., Balloy B.C., Breuer J., Janin A., Dubertret L., Vilmer C., Basset-Seguin N. Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors. Br J Dermatol 2007, 156:448-453.
28. Sander C.S., Ali I., Dean D., Thiele J.J., Wojnarowska F. Oxidative stress is implicated in the pathogenesis of lichen sclerosus. Br J Dermatol 2004, 151:627-635.
29. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-622.
30. Giaginis C., Vgenopoulou S., Vielh P., Theocharis S. MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol 2010, 25:351-370.
31. Lerma E., Esteller M., Herman J.G., Prat J. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Hum Pathol 2002, 33:1120-1125.
32. Porter W.M., Francis N., Hawkins D., Dinneen M., Bunker C.B. Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol 2002, 147:1159-1165.
33. Sergeant A., Vernall N., Mackintosh L.J., McHenry P., Leman J.A. Squamous cell carcinoma arising in extragenital lichen sclerosus. Clin Exp Dermatol 2009, 34:e278-e279.
34. van der Avoort I.A., van de Nieuwenhof H.P., Otte-Höller I., Nirmala E., Bulten J., Massuger L.F., van der Laak J.A., Slootweg P.J., de Hullu J.A., van Kempen L.C. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva. Hum Pathol 2010, 41:1475-1485.
35. Chen H., Gonzalez J.L., Brennick J.B., Liu M., Yan S. Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A. Am J Surg Pathol 2010, 34:1250-1257.